Acinetobacter ursingii: Difference between revisions
From IDWiki
Acinetobacter ursingii
(Created page with "{{DISPLAYTITLE:''Acinetobacter ursingii''}} == Background == === Microbiology === * Non-motile, aerobic, oxidase Oxidase::negative, non-fermentative, Stain::Gram-nega...") |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:''Acinetobacter ursingii''}} |
{{DISPLAYTITLE:''Acinetobacter ursingii''}} |
||
| − | == |
+ | ==Background== |
| − | === |
+ | ===Microbiology=== |
| − | * |
+ | *Non-motile, aerobic, oxidase [[Oxidase::negative]], non-fermentative, [[Stain::Gram-negative]] [[Shape::coccobacillus]] |
| − | * |
+ | *Member of the genus [[Acinetobacter species|Acinetobacter]] with low pathogenicity |
| − | === |
+ | ===Epidemiology=== |
| − | * |
+ | *Rare cause of disease in humans |
| − | * |
+ | *Mostly affects immunocompromised patients or critically ill patients |
| + | *Possible association with malignancy |
||
| − | == |
+ | ==Clinical Manifestations== |
| − | * |
+ | *Primary [[bacteremia]] |
| + | *[[Urinary tract infection]] |
||
| − | * Pneumonia |
||
| + | *Hospital-associated pneumonia |
||
| − | == |
+ | == Management == |
| + | * Often susceptible, but should still treat broadly (e.g. [[meropenem]]) and narrow based on susceptibilities |
||
| ⚫ | |||
| + | |||
| + | ==Further Reading== |
||
| + | |||
| ⚫ | |||
| + | *Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. ''J Clin Microbiol''. 2006;44(12):4471-4478. doi: [https://doi.org/10.1128/JCM.01535-06 10.1128/JCM.01535-06] |
||
[[Category:Gram-negative bacilli]] |
[[Category:Gram-negative bacilli]] |
||
Latest revision as of 10:44, 7 February 2021
Background
Microbiology
- Non-motile, aerobic, oxidase negative, non-fermentative, Gram-negative coccobacillus
- Member of the genus Acinetobacter with low pathogenicity
Epidemiology
- Rare cause of disease in humans
- Mostly affects immunocompromised patients or critically ill patients
- Possible association with malignancy
Clinical Manifestations
- Primary bacteremia
- Urinary tract infection
- Hospital-associated pneumonia
Management
- Often susceptible, but should still treat broadly (e.g. meropenem) and narrow based on susceptibilities
Further Reading
- A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii. BMC Infect Dis. 2015;15(400). doi: 10.1186/s12879-015-1145-z
- Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. J Clin Microbiol. 2006;44(12):4471-4478. doi: 10.1128/JCM.01535-06
